Article
Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study.
Clinical lung cancer - 1 Jan 2023
Mordant Pierre, Brosseau Solenn, Milleron Bernard, Santelmo Nicola, Fraboulet-Moreau Séverine, Besse Benjamin, Langlais Alexandra, Gossot Dominique, Thomas Pascal-Alexandre, Pujol Jean-Louis, Ricordel Charles, Madelaine Jeannick, Lamy Régine, Audigier-Valette Clarisse, Missy Pascale, Blons Hélène, Barlesi Fabrice, Westeel Virginie
Abstract excerpt
INTRODUCTION: Molecular profile of resected stage I-II non-small cell lung cancer (NSCLC) would help refine prognosis and personalize induction or adjuvant strategies. We sought to report the molecular profile of resected stage I-II NSCLC and analyzed the impact of epidermal growth factor receptor (EGFR) mutations on outcomes in a Western population. PATIENTS AND METHODS: Surgical cases were identified from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
